Unified Patent court invalidates Dexcom diabetes patent
A decision by the Paris local division of the Unified Patent Court (UPC) has invalidated a patent of medtech company Dexcom across the 17 participating states of the new pan-European patent system. The ruling is the latest round in an ongoing battle …